Global Vaccines Market Insights and Forecast to 2028

Report ID: 1198197 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Recombinant Vaccines
        1.2.3 Viral Vaccines
        1.2.4 Polysaccharide Vaccines
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Rabies vaccine
        1.3.3 Influenza vaccine
        1.3.4 HPV vaccine
        1.3.5 Hepatitis B
        1.3.6 Hepatitis A
        1.3.7 Leprosy vaccine
        1.3.8 Polio vaccine
        1.3.9 JE vaccine
        1.3.10 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Vaccines Sales by Region
        2.4.1 Global Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Vaccines by Region (2023-2028)
    2.5 Global Vaccines Revenue by Region
        2.5.1 Global Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Vaccines Sales by Manufacturers
        3.1.1 Global Top Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines in 2021
    3.2 Global Vaccines Revenue by Manufacturers
        3.2.1 Global Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Vaccines Revenue in 2021
    3.3 Global Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Vaccines Sales by Type
        4.1.1 Global Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Vaccines Revenue by Type
        4.2.1 Global Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Vaccines Price by Type
        4.3.1 Global Vaccines Price by Type (2017-2022)
        4.3.2 Global Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Vaccines Sales by Application
        5.1.1 Global Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Vaccines Revenue by Application
        5.2.1 Global Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Vaccines Price by Application
        5.3.1 Global Vaccines Price by Application (2017-2022)
        5.3.2 Global Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Vaccines Market Size by Type
        6.1.1 North America Vaccines Sales by Type (2017-2028)
        6.1.2 North America Vaccines Revenue by Type (2017-2028)
    6.2 North America Vaccines Market Size by Application
        6.2.1 North America Vaccines Sales by Application (2017-2028)
        6.2.2 North America Vaccines Revenue by Application (2017-2028)
    6.3 North America Vaccines Market Size by Country
        6.3.1 North America Vaccines Sales by Country (2017-2028)
        6.3.2 North America Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Vaccines Market Size by Type
        7.1.1 Europe Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Vaccines Revenue by Type (2017-2028)
    7.2 Europe Vaccines Market Size by Application
        7.2.1 Europe Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Vaccines Revenue by Application (2017-2028)
    7.3 Europe Vaccines Market Size by Country
        7.3.1 Europe Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Vaccines Market Size by Type
        8.1.1 Asia Pacific Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Vaccines Market Size by Application
        8.2.1 Asia Pacific Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Vaccines Market Size by Region
        8.3.1 Asia Pacific Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Vaccines Market Size by Type
        9.1.1 Latin America Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Vaccines Market Size by Application
        9.2.1 Latin America Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Vaccines Market Size by Country
        9.3.1 Latin America Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Vaccines Market Size by Type
        10.1.1 Middle East and Africa Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Vaccines Market Size by Application
        10.2.1 Middle East and Africa Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Vaccines Market Size by Country
        10.3.1 Middle East and Africa Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GSK
        11.1.1 GSK Corporation Information
        11.1.2 GSK Overview
        11.1.3 GSK Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GSK Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GSK Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Corporation Information
        11.2.2 Sanofi Overview
        11.2.3 Sanofi Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Recent Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Corporation Information
        11.4.2 Pfizer Overview
        11.4.3 Pfizer Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Pfizer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Pfizer Recent Developments
    11.5 Novartis(GSK)
        11.5.1 Novartis(GSK) Corporation Information
        11.5.2 Novartis(GSK) Overview
        11.5.3 Novartis(GSK) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Novartis(GSK) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Novartis(GSK) Recent Developments
    11.6 CSL
        11.6.1 CSL Corporation Information
        11.6.2 CSL Overview
        11.6.3 CSL Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 CSL Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 CSL Recent Developments
    11.7 MedImmune LLC
        11.7.1 MedImmune LLC Corporation Information
        11.7.2 MedImmune LLC Overview
        11.7.3 MedImmune LLC Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 MedImmune LLC Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 MedImmune LLC Recent Developments
    11.8 J&J(Crucell)
        11.8.1 J&J(Crucell) Corporation Information
        11.8.2 J&J(Crucell) Overview
        11.8.3 J&J(Crucell) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 J&J(Crucell) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 J&J(Crucell) Recent Developments
    11.9 China National Biotec
        11.9.1 China National Biotec Corporation Information
        11.9.2 China National Biotec Overview
        11.9.3 China National Biotec Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 China National Biotec Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 China National Biotec Recent Developments
    11.10 Tiantan
        11.10.1 Tiantan Corporation Information
        11.10.2 Tiantan Overview
        11.10.3 Tiantan Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Tiantan Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Tiantan Recent Developments
    11.11 Hualan
        11.11.1 Hualan Corporation Information
        11.11.2 Hualan Overview
        11.11.3 Hualan Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Hualan Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Hualan Recent Developments
    11.12 Kangtai
        11.12.1 Kangtai Corporation Information
        11.12.2 Kangtai Overview
        11.12.3 Kangtai Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Kangtai Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Kangtai Recent Developments
    11.13 Hissen
        11.13.1 Hissen Corporation Information
        11.13.2 Hissen Overview
        11.13.3 Hissen Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Hissen Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Hissen Recent Developments
    11.14 Jintan
        11.14.1 Jintan Corporation Information
        11.14.2 Jintan Overview
        11.14.3 Jintan Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Jintan Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Jintan Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Vaccines Industry Chain Analysis
    12.2 Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Vaccines Production Mode & Process
    12.4 Vaccines Sales and Marketing
        12.4.1 Vaccines Sales Channels
        12.4.2 Vaccines Distributors
    12.5 Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Vaccines Industry Trends
    13.2 Vaccines Market Drivers
    13.3 Vaccines Market Challenges
    13.4 Vaccines Market Restraints
14 Key Findings in The Global Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Recombinant Vaccines
    Table 3. Major Manufacturers of Viral Vaccines
    Table 4. Major Manufacturers of Polysaccharide Vaccines
    Table 5. Major Manufacturers of Others
    Table 6. Global Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Vaccines Sales by Region (2017-2022) & (K Pcs)
    Table 9. Global Vaccines Sales Market Share by Region (2017-2022)
    Table 10. Global Vaccines Sales by Region (2023-2028) & (K Pcs)
    Table 11. Global Vaccines Sales Market Share by Region (2023-2028)
    Table 12. Global Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Vaccines Revenue Market Share by Region (2017-2022)
    Table 14. Global Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Vaccines Revenue Market Share by Region (2023-2028)
    Table 16. Global Vaccines Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 17. Global Vaccines Sales Share by Manufacturers (2017-2022)
    Table 18. Global Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 20. Vaccines Price by Manufacturers (2017-2022) &(US$/Pcs)
    Table 21. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines as of 2021)
    Table 23. Vaccines Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Vaccines Product Offered
    Table 25. Date of Manufacturers Enter into Vaccines Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Vaccines Sales by Type (2017-2022) & (K Pcs)
    Table 28. Global Vaccines Sales by Type (2023-2028) & (K Pcs)
    Table 29. Global Vaccines Sales Share by Type (2017-2022)
    Table 30. Global Vaccines Sales Share by Type (2023-2028)
    Table 31. Global Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Vaccines Revenue Share by Type (2017-2022)
    Table 34. Global Vaccines Revenue Share by Type (2023-2028)
    Table 35. Vaccines Price by Type (2017-2022) & (US$/Pcs)
    Table 36. Global Vaccines Price Forecast by Type (2023-2028) & (US$/Pcs)
    Table 37. Global Vaccines Sales by Application (2017-2022) & (K Pcs)
    Table 38. Global Vaccines Sales by Application (2023-2028) & (K Pcs)
    Table 39. Global Vaccines Sales Share by Application (2017-2022)
    Table 40. Global Vaccines Sales Share by Application (2023-2028)
    Table 41. Global Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Vaccines Revenue Share by Application (2017-2022)
    Table 44. Global Vaccines Revenue Share by Application (2023-2028)
    Table 45. Vaccines Price by Application (2017-2022) & (US$/Pcs)
    Table 46. Global Vaccines Price Forecast by Application (2023-2028) & (US$/Pcs)
    Table 47. North America Vaccines Sales by Type (2017-2022) & (K Pcs)
    Table 48. North America Vaccines Sales by Type (2023-2028) & (K Pcs)
    Table 49. North America Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Vaccines Sales by Application (2017-2022) & (K Pcs)
    Table 52. North America Vaccines Sales by Application (2023-2028) & (K Pcs)
    Table 53. North America Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Vaccines Sales by Country (2017-2022) & (K Pcs)
    Table 56. North America Vaccines Sales by Country (2023-2028) & (K Pcs)
    Table 57. North America Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Vaccines Sales by Type (2017-2022) & (K Pcs)
    Table 60. Europe Vaccines Sales by Type (2023-2028) & (K Pcs)
    Table 61. Europe Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Vaccines Sales by Application (2017-2022) & (K Pcs)
    Table 64. Europe Vaccines Sales by Application (2023-2028) & (K Pcs)
    Table 65. Europe Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Vaccines Sales by Country (2017-2022) & (K Pcs)
    Table 68. Europe Vaccines Sales by Country (2023-2028) & (K Pcs)
    Table 69. Europe Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Vaccines Sales by Type (2017-2022) & (K Pcs)
    Table 72. Asia Pacific Vaccines Sales by Type (2023-2028) & (K Pcs)
    Table 73. Asia Pacific Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Vaccines Sales by Application (2017-2022) & (K Pcs)
    Table 76. Asia Pacific Vaccines Sales by Application (2023-2028) & (K Pcs)
    Table 77. Asia Pacific Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Vaccines Sales by Region (2017-2022) & (K Pcs)
    Table 80. Asia Pacific Vaccines Sales by Region (2023-2028) & (K Pcs)
    Table 81. Asia Pacific Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Vaccines Sales by Type (2017-2022) & (K Pcs)
    Table 84. Latin America Vaccines Sales by Type (2023-2028) & (K Pcs)
    Table 85. Latin America Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Vaccines Sales by Application (2017-2022) & (K Pcs)
    Table 88. Latin America Vaccines Sales by Application (2023-2028) & (K Pcs)
    Table 89. Latin America Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Vaccines Sales by Country (2017-2022) & (K Pcs)
    Table 92. Latin America Vaccines Sales by Country (2023-2028) & (K Pcs)
    Table 93. Latin America Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Vaccines Sales by Type (2017-2022) & (K Pcs)
    Table 96. Middle East and Africa Vaccines Sales by Type (2023-2028) & (K Pcs)
    Table 97. Middle East and Africa Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Vaccines Sales by Application (2017-2022) & (K Pcs)
    Table 100. Middle East and Africa Vaccines Sales by Application (2023-2028) & (K Pcs)
    Table 101. Middle East and Africa Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Vaccines Sales by Country (2017-2022) & (K Pcs)
    Table 104. Middle East and Africa Vaccines Sales by Country (2023-2028) & (K Pcs)
    Table 105. Middle East and Africa Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 107. GSK Corporation Information
    Table 108. GSK Description and Major Businesses
    Table 109. GSK Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 110. GSK Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. GSK Recent Developments
    Table 112. Sanofi Corporation Information
    Table 113. Sanofi Description and Major Businesses
    Table 114. Sanofi Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 115. Sanofi Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Sanofi Recent Developments
    Table 117. Merck Corporation Information
    Table 118. Merck Description and Major Businesses
    Table 119. Merck Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 120. Merck Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Merck Recent Developments
    Table 122. Pfizer Corporation Information
    Table 123. Pfizer Description and Major Businesses
    Table 124. Pfizer Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 125. Pfizer Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Pfizer Recent Developments
    Table 127. Novartis(GSK) Corporation Information
    Table 128. Novartis(GSK) Description and Major Businesses
    Table 129. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 130. Novartis(GSK) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Novartis(GSK) Recent Developments
    Table 132. CSL Corporation Information
    Table 133. CSL Description and Major Businesses
    Table 134. CSL Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 135. CSL Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. CSL Recent Developments
    Table 137. MedImmune LLC Corporation Information
    Table 138. MedImmune LLC Description and Major Businesses
    Table 139. MedImmune LLC Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 140. MedImmune LLC Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. MedImmune LLC Recent Developments
    Table 142. J&J(Crucell) Corporation Information
    Table 143. J&J(Crucell) Description and Major Businesses
    Table 144. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 145. J&J(Crucell) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. J&J(Crucell) Recent Developments
    Table 147. China National Biotec Corporation Information
    Table 148. China National Biotec Description and Major Businesses
    Table 149. China National Biotec Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 150. China National Biotec Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. China National Biotec Recent Developments
    Table 152. Tiantan Corporation Information
    Table 153. Tiantan Description and Major Businesses
    Table 154. Tiantan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 155. Tiantan Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Tiantan Recent Developments
    Table 157. Hualan Corporation Information
    Table 158. Hualan Description and Major Businesses
    Table 159. Hualan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 160. Hualan Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Hualan Recent Developments
    Table 162. Kangtai Corporation Information
    Table 163. Kangtai Description and Major Businesses
    Table 164. Kangtai Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 165. Kangtai Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Kangtai Recent Developments
    Table 167. Hissen Corporation Information
    Table 168. Hissen Description and Major Businesses
    Table 169. Hissen Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 170. Hissen Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Hissen Recent Developments
    Table 172. Jintan Corporation Information
    Table 173. Jintan Description and Major Businesses
    Table 174. Jintan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 175. Jintan Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Jintan Recent Developments
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Vaccines Distributors List
    Table 180. Vaccines Customers List
    Table 181. Vaccines Market Trends
    Table 182. Vaccines Market Drivers
    Table 183. Vaccines Market Challenges
    Table 184. Vaccines Market Restraints
    Table 185. Research Programs/Design for This Report
    Table 186. Key Data Information from Secondary Sources
    Table 187. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccines Product Picture
    Figure 3. Global Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Recombinant Vaccines Product Picture
    Figure 4. Viral Vaccines Product Picture
    Figure 5. Polysaccharide Vaccines Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Vaccines Market Share by Application in 2021 & 2028
    Figure 8. Rabies vaccine
    Figure 9. Influenza vaccine
    Figure 10. HPV vaccine
    Figure 11. Hepatitis B
    Figure 12. Hepatitis A
    Figure 13. Leprosy vaccine
    Figure 14. Polio vaccine
    Figure 15. JE vaccine
    Figure 16. Others
    Figure 17. Vaccines Report Years Considered
    Figure 18. Global Vaccines Sales 2017-2028 (K Pcs)
    Figure 19. Global Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Vaccines Revenue 2017-2028 (US$ Million)
    Figure 21. Global Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 22. Global Vaccines Sales Market Share by Region (2017-2022)
    Figure 23. Global Vaccines Sales Market Share by Region (2023-2028)
    Figure 24. North America Vaccines Sales YoY (2017-2028) & (K Pcs)
    Figure 25. North America Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Vaccines Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Europe Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Vaccines Sales YoY (2017-2028) & (K Pcs)
    Figure 29. Asia-Pacific Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Latin America Vaccines Sales YoY (2017-2028) & (K Pcs)
    Figure 31. Latin America Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. Middle East & Africa Vaccines Sales YoY (2017-2028) & (K Pcs)
    Figure 33. Middle East & Africa Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 34. The Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 35. The Top 5 and 10 Largest Manufacturers of Vaccines in the World: Market Share by Vaccines Revenue in 2021
    Figure 36. Global Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 37. Global Vaccines Sales Market Share by Type (2017-2028)
    Figure 38. Global Vaccines Revenue Market Share by Type (2017-2028)
    Figure 39. Global Vaccines Sales Market Share by Application (2017-2028)
    Figure 40. Global Vaccines Revenue Market Share by Application (2017-2028)
    Figure 41. North America Vaccines Sales Market Share by Type (2017-2028)
    Figure 42. North America Vaccines Revenue Market Share by Type (2017-2028)
    Figure 43. North America Vaccines Sales Market Share by Application (2017-2028)
    Figure 44. North America Vaccines Revenue Market Share by Application (2017-2028)
    Figure 45. North America Vaccines Sales Share by Country (2017-2028)
    Figure 46. North America Vaccines Revenue Share by Country (2017-2028)
    Figure 47. U.S. Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. Canada Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. Europe Vaccines Sales Market Share by Type (2017-2028)
    Figure 50. Europe Vaccines Revenue Market Share by Type (2017-2028)
    Figure 51. Europe Vaccines Sales Market Share by Application (2017-2028)
    Figure 52. Europe Vaccines Revenue Market Share by Application (2017-2028)
    Figure 53. Europe Vaccines Sales Share by Country (2017-2028)
    Figure 54. Europe Vaccines Revenue Share by Country (2017-2028)
    Figure 55. Germany Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 56. France Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 57. U.K. Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 58. Italy Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. Russia Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. Asia Pacific Vaccines Sales Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Vaccines Revenue Market Share by Type (2017-2028)
    Figure 62. Asia Pacific Vaccines Sales Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Vaccines Revenue Market Share by Application (2017-2028)
    Figure 64. Asia Pacific Vaccines Sales Share by Region (2017-2028)
    Figure 65. Asia Pacific Vaccines Revenue Share by Region (2017-2028)
    Figure 66. China Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Japan Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. South Korea Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. India Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 70. Australia Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 71. China Taiwan Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 72. Indonesia Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 73. Thailand Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 74. Malaysia Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Latin America Vaccines Sales Market Share by Type (2017-2028)
    Figure 76. Latin America Vaccines Revenue Market Share by Type (2017-2028)
    Figure 77. Latin America Vaccines Sales Market Share by Application (2017-2028)
    Figure 78. Latin America Vaccines Revenue Market Share by Application (2017-2028)
    Figure 79. Latin America Vaccines Sales Share by Country (2017-2028)
    Figure 80. Latin America Vaccines Revenue Share by Country (2017-2028)
    Figure 81. Mexico Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 82. Brazil Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 83. Argentina Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. Middle East and Africa Vaccines Sales Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Vaccines Revenue Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Vaccines Sales Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Vaccines Revenue Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Vaccines Sales Share by Country (2017-2028)
    Figure 89. Middle East and Africa Vaccines Revenue Share by Country (2017-2028)
    Figure 90. Turkey Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 91. Saudi Arabia Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 92. UAE Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 93. Vaccines Value Chain
    Figure 94. Vaccines Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Frequently Asked Questions
Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aseptic Packaging

Aseptic Packaging market is segmented by Package Size and by Application. Players, stakeholders,  ... Read More

Black Masterbatch

Black Masterbatch market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Blood Product

Blood Product market is segmented by players, region (country), by Type and by Application. Playe ... Read More